Vaccines Virtual Conference 2021
Connecting the vaccine industry from across the globe to develop long lasting partnerships and discover solutions to the current challenges.
Covid-19 has become the number one priority for the vaccines industry, having a major impact on practitioners in the field. With a greater need than ever for collaboration, we are delighted to bring you a one-day virtual experience to bring together key global leaders in the vaccines industry.
Delivered to a global audience, our virtual conference will bring together C-level figures from leading pharma giants, biotechs and pioneering organizations, ensuring that the top minds are present to lead first class content.
Why Join Our Virtual Experience?
- Watch cutting edge presentations from 25+ speakers
- Connect with industry leaders - GlaxoSmithKline, Gilead and Sanofi along with established Biotechs
- Diverse Sessions – dedicated talks on manufacturing processes, clinical developments and regulatory updates
- Meet a global audience – Chat with experts in vaccine developments
A FANTASTIC NETWORK OF YOUR PEERS AND COLLEAGUES RIGHT AT A TAP OR CLICK OF A BUTTON
Simply register, login on the day and get ready to connect and learn. With the right network at your fingertips, learning and connecting have never been so easy.
💻 Watch live and recorded thought leadership presentations
🗣️ Take part in live Q&A with industry experts from across the globe
👩💻 One-to-one & group video chat with each solution provider
🤝 Chat & network with anyone on the platform
📊 Take part in our interactive polls
👥 Join live panel debates and discussions
🛍️ Download resources from solution providers to your event bag
‘That was a superb day, it feels like we’ve been at a real, in person, conference!’ Worldwide Clinical Trials
‘A great event, I met more people than I do at an in-person event and I’ve got loads of
follow ups’ Conversis
‘The whole setting is actually very well accomplished! Thanks again for the invitation!’ Apogenix AG
With over 40 years’ experience, 600 beds and locations in NA, EU and Asia, Celerion conducts First-in-Human, clinical Proof-of-Concept and patient dose response studies, cardiovascular safety and NDA-enabling clinical pharmacology research. Celerion provides full study services including statistics, data management and biostatistics (including PK/PD analysis), and bioanalytical services.
Alexander O’ Leary
Portfolio Director – OCT EMEA and Pharma Packaging & Labelling Global
T: +44 207 936 6690
The Clinical Trials In Vaccines programme is written in collaboration with industry, if you have a case study, idea or just a comment, please contact:
Senior Conference Producer
T: + 44 (0) 2079366 607